Laura Riccetti
Overview
Explore the profile of Laura Riccetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casarini L, Lazzaretti C, Paradiso E, Limoncella S, Riccetti L, Sperduti S, et al.
iScience
. 2020 Dec;
23(12):101812.
PMID: 33299978
Classically, follicle-stimulating hormone receptor (FSHR)-driven cAMP-mediated signaling boosts human ovarian follicle growth and oocyte maturation. However, contradicting data suggest a different view on physiological significance of FSHR-mediated cAMP signaling. We...
2.
Casarini L, Riccetti L, Paradiso E, Benevelli R, Lazzaretti C, Sperduti S, et al.
Mol Hum Reprod
. 2020 Oct;
26(12):894-905.
PMID: 33084890
Commercial hMG drugs are marketed for the treatment of infertility and consist of highly purified hormones acting on receptors expressed in target gonadal cells. Menopur® and Meriofert® are combined preparation...
3.
Sperduti S, Limoncella S, Lazzaretti C, Paradiso E, Riccetti L, Turchi S, et al.
Int J Mol Sci
. 2019 Nov;
20(22).
PMID: 31703269
Commercial gonadotropin-releasing hormone (GnRH) antagonists differ by 1-2 amino acids and are used to inhibit gonadotropin production during assisted reproduction technologies (ART). In this study, potencies of three GnRH antagonists,...
4.
Vorbach S, Grunder A, Zhou F, Koellerer C, Jutzi J, Simoni M, et al.
Leukemia
. 2019 Oct;
34(3):721-734.
PMID: 31636343
Acute myeloid leukemia (AML) carries a 10-100 fold lower mutational burden than other neoplastic entities. Mechanistic explanations for why a low number of mutations suffice to induce leukemogenesis are therefore...
5.
Riccetti L, Sperduti S, Lazzaretti C, Klett D, De Pascali F, Paradiso E, et al.
Front Endocrinol (Lausanne)
. 2019 Aug;
10:503.
PMID: 31396162
Recombinant follicle-stimulating hormone (FSH) (follitropin alfa) and biosimilar preparations are available for clinical use. They have specific FSH activity and a unique glycosylation profile dependent on source cells. The aim...
6.
Lazzaretti C, Riccetti L, Sperduti S, Anzivino C, Brigante G, De Pascali F, et al.
Reprod Biomed Online
. 2019 Mar;
38(5):816-824.
PMID: 30910395
Research Question: What is the cumulative effect of two follicle-stimulating hormone receptor (FSHR) mutations in spontaneous ovarian hyperstimulation syndrome (sOHSS) pathogenesis? Are these mutations in the mono- or biallelic state?...
7.
Brigante G, Riccetti L, Lazzaretti C, Rofrano L, Sperduti S, Poti F, et al.
Mol Cell Endocrinol
. 2018 Dec;
482:37-44.
PMID: 30543878
Growth Hormone (GH) deficiency is frequent in HIV-infected patients treated with antiretroviral therapy. We treated GH3 cells with antiretrovirals (nevirapine, ritonavir or abacavir sulfate; 100 pM-1 mM range), after transfection...
8.
Casarini L, Riccetti L, Limoncella S, Lazzaretti C, Barbagallo F, Pacifico S, et al.
Biochemistry
. 2018 Dec;
58(6):799-808.
PMID: 30532959
Forster resonance energy transfer (FRET)-based biosensors have been recently applied to the study of biological pathways. In this study, a new biosensor was validated for the first time in live...
9.
Riccetti L, Sperduti S, Lazzaretti C, Casarini L, Simoni M
Minerva Ginecol
. 2018 Aug;
70(5):516-524.
PMID: 30160084
Pituitary gonadotropins, follicle-stimulating (FSH) and luteinizing hormone (LH) promote follicular recruitment and support antral follicle growth, maturation and selection, resulting in ovulation of the dominant follicle. FSH and LH biological...
10.
Riccetti L, Klett D, Ayoub M, Boulo T, Pignatti E, Tagliavini S, et al.
Mol Hum Reprod
. 2017 Oct;
23(10):685-697.
PMID: 29044421
Study Question: Are four urinary hCG/menotropin (hMG) and one recombinant preparation characterized by different molecular features and do they mediate specific intracellular signaling and steroidogenesis? Summary Answer: hCG and hMG...